PATENT CLAIM ANALYSIS

Application Number: 15765325
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "052000"]

Abstract:
The invention relates to crystalline forms of a β-nicotinamide mononucleotide, methods of their preparation, and related pharmaceutical preparations thereof. The invention also relates to preparations suitable for nutraceutical, veterinary, and agriculturally-relevant uses.

Claim (Index 16):
The method of  claim 15 , wherein the crystalline compound is anhydrous.

Metadata:
- Claim Count in Document: 4.0
- Percentile: 91.0
- Lexical Diversity: 1.40741
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15512388', '15877597', '14434573', '15315160', '15570210']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7196733247883914
- 35 USC 102 Novelty (BERT): 0.4704030721956692
- Combined Prediction Score: 0.6947462995291191
- Mean Citation Score: 139.631034
- Max Citation Score: 149.45332
- Similarity Product: 112.12232644673824

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test